^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HRYZ-T101

    i
    Other names: HRYZ-T101
    Associations

    News

    Trials
    Company:
    HRYZ BIOTECH
    Drug class:
    TCR modulator
    Related drugs:
    Associations

    News

    Trials
    10ms
    HRYZ-T101 Injection for HPV18 Positive Solid Tumor (clinicaltrials.gov)
    P1, N=32, Recruiting, HRYZ Biotech Co. | Not yet recruiting --> Recruiting
    Enrollment open
    |
    HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1)
    |
    cyclophosphamide • fludarabine IV • HRYZ-T101
    1year
    HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor (clinicaltrials.gov)
    P1, N=17, Recruiting, HRYZ Biotech Co. | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1)
    |
    cyclophosphamide • fludarabine IV • HRYZ-T101
    over1year
    HRYZ-T101 Injection for HPV18 Positive Solid Tumor (clinicaltrials.gov)
    P1, N=32, Not yet recruiting, SYZ Cell Therapy Co..
    New P1 trial
    |
    HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1)
    |
    cyclophosphamide • fludarabine IV • HRYZ-T101
    over1year
    HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor (clinicaltrials.gov)
    P1, N=17, Not yet recruiting, SYZ Cell Therapy Co..
    New P1 trial • Metastases
    |
    HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1)
    |
    cyclophosphamide • fludarabine IV • HRYZ-T101